SCHEMBL4445145

SCHEMBL4445145

CC(C)(C)OC(=O)N(c1ccc(S(C)(=O)=O)cc1[N+](=O)[O-])C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.41
ALDH1A1 P00352 5/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 2/20 0.36
VCAM1 P19320 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
CCR6 P51684 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH3A1 P30838 1/20 0.35
GPR119 Q8TDV5 5/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4433895 0.87 KDM4E (0.39) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL4434450 0.86 TACR1 (0.38) ALDH1A1HTTKMT2AMEN1MAPT
SCHEMBL4444516 0.86 MAPK1 (0.40) ALDH1A1HTTKMT2AMEN1MAPT
SCHEMBL4437157 0.85 HCAR3 (0.39) CYP2C9HTTKDM4EVCAM1KMT2A
SCHEMBL4437504 0.85 MAPT (0.45) CYP2C9ALDH1A1KMT2AMEN1MAPT
SCHEMBL4439400 0.85 POLB (0.40) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL4434940 0.83 MEN1 (0.39) HTTKDM4EVCAM1KMT2AMEN1
SCHEMBL4438391 0.83 KMT2A (0.36) CYP2C9ALDH1A1HTTKDM4EKMT2A
SCHEMBL4444969 0.82 VCAM1 (0.42) ALDH1A1HTTKDM4EVCAM1KMT2A
SCHEMBL4434425 0.81 KDM4E (0.39) ALDH1A1KDM4EKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed